Product correctly added to cart.

discount label
TAS 6417 hydrochloride
View 3D

Biosynth logo

TAS 6417 hydrochloride

CAS: 1661854-97-2

Ref. 3D-BT171643

5mg
271.00 €
10mg
386.00 €
25mg
678.00 €
50mg
861.00 €
100mg
1,379.00 €
Estimated delivery in United States, on Friday 31 Jan 2025

Product Information

Name:
TAS 6417 hydrochloride
Description:

TAS 6417 hydrochloride is a natural compound that has potent antitumor activity. It can induce apoptosis in cancer cells by inhibiting the growth of cancer cells and inducing cell cycle arrest. TAS 6417 hydrochloride inhibits the production of epidermal growth factor, which is a potent growth factor for tumor cells. This drug also has potent inhibitory effects on the production of other cytokines such as interleukin-2 and interleukin-6. TAS 6417 hydrochloride was shown to have a clinical response rate of 50% in patients with advanced solid tumors, including breast cancer and pancreatic cancer. It also has been shown to have an effect on women with breast cancer, with an improvement in prognosis and quality of life seen in some studies.br>br>br>

Notice:
Our products are intended for lab use only. For any other use, please contact us.
Brand:
Biosynth
Long term storage:
Notes:

Chemical properties

Molecular weight:
432.91 g/mol
Formula:
C23H20N6O·HCl
Purity:
Min. 95%
MDL:
Melting point:
Boiling point:
Flash point:
Density:
Concentration:
EINECS:
Merck:
HS code:

Hazard Info

UN Number:
EQ:
Class:
H Statements:
P Statements:
Forbidden to fly:
Hazard Info:
Packing Group:
LQ:

Technical inquiry about: 3D-BT171643 TAS 6417 hydrochloride

Please use instead the cart to request a quotation or an order

If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.

* Mandatory fields.
Welcome to CymitQuimica!We use cookies to enhance your visit. We do not include advertising.

Please see our Cookies Policy for more details or adjust your preferences in "Settings".